Myasthenia Gravis/Lambert-Eaton Eval LEABX
Synonyms |
|
Allscripts (AEHR) Order Name |
Myasthenia Gravis/Lambert - Eaton Eval |
Sunrise Clinical Manager (SCM) Order Name |
Myasthenia Gravis/Lambert - Eaton Eval. |
EPIC Order Name |
Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation |
Clinical Info |
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody baseline for future comparisons in monitoring a patient's clinical course and response to immunomodulatory treatment |
Specimen Type |
Blood |
Specimen Volume |
3 mL serum ( 2 mL min) |
Container |
Red Top Tube |
Collection Instructions |
Container/Tube: Red top tube or Gold Top Tube |
Transport Instructions |
|
Specimen Stability |
72 Hours Room Temperature |
Methodology |
ARBI, CCPQ, MUSK: Radioimmunoassay (RIA)ACMFS: Flow Cytometry |
Days Performed |
|
Performing Laboratory |
Mayo Medical Laboratories |
CPT |
83519 x 2 |
PDM |
5910940 |
Result Interpretation
MG Lambert-Eaton Interpretation, S Interpretation NA
ACh Receptor (Muscle) Binding Ab Radioimmunoassay (RIA) < or =0.02 nmol/L P/Q-Type Calcium Channel Ab RIA < or =0.02 nmol/L |
|
Forms |
|
